My bookmarksSign up free

Commission Regulation (EU) No 957/2010 ANNEX II

Commission Regulation (EU) No 957/2010 ANNEX II

ANNEX IISupplementary provisions

ANNEX II Rejected health claims Application — Relevant provisions of Regulation (EC) No 1924/2006 Nutrient, substance, food or food category Claim EFSA opinion reference Article 14(1)(a) health claim referring to a reduction of a disease risk OPC Premium™ OPC have been shown to reduce blood cholesterol levels and may therefore reduce the risk of cardiovascular disease Q-2009-00454 Article 14(1)(a) health claim referring to a reduction of a disease risk Uroval® Cranberry extract and D-mannose, the main active ingredients of the food supplement Uroval®, eliminate the adhesion of harmful bacteria to the bladder wall. The adhesion of harmful bacteria to the bladder wall is the main risk factor in the development of urinary tract infections Q-2009-00600 Article 14(1)(b) health claim referring to children’s development and health Combination of bifidobacteria ( Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum ) Probiotic bifidobacteria lead to a healthy intestinal flora comparable to the composition of the intestinal flora of breast-fed infants’ intestine Q-2009-00224

Read the full instrument →

Other provisions in Commission Regulation (EU) No 957/2010

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationANNEX II of Commission Regulation (EU) No 957/2010 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next